White House To Kick Off Surprise Billing Rulemaking With Interim Final Rule

By Amy Lotven / June 9, 2021 at 7:53 PM
The first part of the highly anticipated rulemaking on the surprise billing legislation enacted late last year is now under review by the White House Office of Management and Budget (OMB), surprising some stakeholders who expected CMS might miss early deadlines. The interim final rule is expected to encompass provisions of the No Surprise Act -- including the formula for the critical “qualified payment amount” and guidance on informed consent -- that are statutorily required to be out by July...

Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on drug pricing reforms, Medicaid policy, FDA news and much more.